[
    [
        {
            "time": "2021-Q1",
            "original_text": "【中金医药】2021年一季度业绩预览：核心标的增长强劲，调整是布局良机",
            "features": {
                "keywords": [
                    "中金医药",
                    "2021年一季度",
                    "核心标的",
                    "增长强劲",
                    "布局良机"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【中金医药】2021年一季度业绩预览：核心标的增长强劲，调整是布局良机",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-03-21",
            "original_text": "又一国产PD-1治疗肺癌适应证上市，或惠及超半数肺癌患者",
            "features": {
                "keywords": [
                    "国产PD-1",
                    "肺癌",
                    "适应证",
                    "上市",
                    "惠及"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "又一国产PD-1治疗肺癌适应证上市，或惠及超半数肺癌患者",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-21",
            "original_text": "角膜塑形镜利于儿童近视防控，重点推荐欧普康视、昊海生科等【东吴医药朱国广团队|0321周报】",
            "features": {
                "keywords": [
                    "角膜塑形镜",
                    "儿童近视",
                    "欧普康视",
                    "昊海生科",
                    "东吴医药"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗器械",
                    "眼科"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "角膜塑形镜利于儿童近视防控，重点推荐欧普康视、昊海生科等【东吴医药朱国广团队|0321周报】",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-WEEKLY",
            "original_text": "医药生物行业周报：基因细胞治疗CDMO黄金赛道有望孕育下一个药明生物",
            "features": {
                "keywords": [
                    "医药生物",
                    "基因细胞治疗",
                    "CDMO",
                    "黄金赛道",
                    "药明生物"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "基因治疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业周报：基因细胞治疗CDMO黄金赛道有望孕育下一个药明生物",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]